Johnson & Johnson (JNJ) Treasury Shares (2009 - 2026)
Johnson & Johnson (JNJ) posted Treasury Shares of $76.3 billion for Q1 2026, up 0.85% sequentially from $75.6 billion in Q4 2025, and little changed YoY from $75.9 billion in Q1 2025.
Johnson & Johnson (JNJ) Treasury Shares (2009 - 2026) Analysis & Trends
Johnson & Johnson (JNJ) has 18 years of Treasury Shares data on file, last reported at $76.3 billion in Q1 2026.
- Quarterly Treasury Shares changed 0.47% year-over-year to $76.3 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $76.3 billion (changed 0.47% YoY) and the FY2025 annual result came in at $75.6 billion, changed 0.07% from the prior year.
- Treasury Shares advanced to $76.3 billion in Q1 2026 per JNJ's latest filing, from $75.6 billion in the prior quarter.
- The five-year high for Treasury Shares was $714.2 million in Q1 2025, with the low at $490.5 million in Q2 2022.
- Average Treasury Shares over 5 years is $631.5 million, with a median of $712.6 million recorded in 2023.
- Year-over-year, Treasury Shares surged 83.85% in 2023 and fell 0.07% in 2025.
- Johnson & Johnson's Treasury Shares stood at $41.1 billion in 2022, then surged by 83.89% to $75.7 billion in 2023, then advanced by 0.02% to $75.7 billion in 2024, then decreased by 0.07% to $75.6 billion in 2025, then advanced by 0.85% to $76.3 billion in 2026.
- Business Quant data shows JNJ's Treasury Shares at $76.3 billion in Q1 2026, $75.6 billion in Q4 2025, and $75.9 billion in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,066.16 Bn | 1,060.88 Bn | 16.22 Bn | 3.01 Bn |
| 2 | Johnson & Johnson | 611.69 Bn | 589.64 Bn | 15.96 Bn | 76.26 Bn |
| 3 | AbbVie | 444.34 Bn | 434.99 Bn | 10.78 Bn | 10.61 Bn |
| 4 | Astrazeneca | 284.94 Bn | 277.05 Bn | 12.61 Bn | - |
| 5 | Merck | 224.23 Bn | 218.58 Bn | 12.09 Bn | 1.11 Bn |
| 6 | Amgen | 195.12 Bn | 183.08 Bn | 5.87 Bn | - |
| 7 | Gilead Sciences | 156.45 Bn | 148.73 Bn | 5.52 Bn | - |
| 8 | Pfizer | 136.01 Bn | 123.24 Bn | -1.21 Bn | 3.94 Bn |
| 9 | Novartis Ag | 113.45 Bn | 113.67 Bn | - | -47.00 Mn |
| 10 | Biogen | 30.87 Bn | 26.59 Bn | 1.82 Bn | 2.98 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 29, 2026 | 713.26 Mn |
| Mar 29, 2026 | 76.26 Bn |
| Mar 29, 2026 | 713.26 Mn |
| Mar 29, 2026 | 76.26 Bn |
| Dec 28, 2025 | 711.90 Mn |
| Dec 28, 2025 | 75.62 Bn |
| Dec 28, 2025 | 75.62 Bn |
| Dec 28, 2025 | 711.90 Mn |
| Sep 28, 2025 | 75.89 Bn |
| Sep 28, 2025 | 75.89 Bn |
| Sep 28, 2025 | 713.65 Mn |
| Sep 28, 2025 | 713.65 Mn |
| Jun 29, 2025 | 75.71 Bn |
| Jun 29, 2025 | 713.06 Mn |
| Jun 29, 2025 | 713.06 Mn |
| Jun 29, 2025 | 75.71 Bn |
| Mar 30, 2025 | 714.22 Mn |
| Mar 30, 2025 | 75.91 Bn |
| Mar 30, 2025 | 75.91 Bn |
| Mar 30, 2025 | 714.22 Mn |